Skip to main content

Rush Biomarker Development Core

The Rush Biomarker Development Core, located in the Jelke building on the Rush University Medical Center campus, offers a cost-effective strategy for investigators who need to measure and/or monitor protein biomarkers as part of their research objectives. Our Luminex xMAP platform is ideal for researchers involved in drug discovery, diagnostics and translational science projects — from pilot project to clinical trial. We also provide comprehensive guidance and consultation for a range of potential grant and industry-sponsored research applications to help maximize your potential for successful funding.

Equipment capabilities

The Biomarker Development Core's primary platform is the Luminex xMAP Technology, which can assay up to 500 analytes at once by means of a very high-throughput yet cost-effective process that requires only small amounts of specimen.

Services offered

Available services include these:

  • User training for assay performance
  • "Full service" measurement of biomarkers by facility personnel
  • Consultation and troubleshooting
  • Custom assay development for any analyte (including analytical validation)
  • Data processing and statistical analysis

If you don’t see the specific assays you are looking for, we are very experienced at developing custom assays for a variety of applications. Please inquire about metabolomic applications.


Expected turnaround times

Quick, three-business-day turnover for most jobs


Please contact the core for an estimate.

Contact Us

1750 W. Harrison St.

Jelke Building South, Suite 444

Chicago, IL 60612

Phone: (312) 942-2210

Core director

Jeffrey A. Borgia, PhD 


Core Manager

Cristina Fhied, MS